Explore disease physiology and more with iPSC reprogramming services from a company with over 15 years of successful iPSC services
When it comes to iPSC generation, we don’t believe in a one-size-fits-all approach. We offer reprogramming via multiple vectors, including retroviruses, Sendai virus, and episomal plasmids.
We work with you to ensure that the iPSC reprogramming method delivers optimal performance for your study goals and the cells being reprogrammed, whether you are conducting basic research, drug discovery studies, drug screening, or preclinical cell regeneration projects.
Trust your critical cell line reprogramming to our experienced scientists. All work conducted in our US labs.
iPSCs reprogrammed from PBMCs by the Applied StemCell team.
Nakamura BN, Sedighi S, Das D, Joshi RM, Neman J. Chromosome 2q31.2 Deletion Impairs Neuronal Plasticity through Integrated Stress Response Activation. bioRxiv. Preprint posted online April 28, 2026:2026.04.24.720735. doi:10.64898/2026.04.24.720735
Corti S, Kim KH, Chen T, et al. Recreating pathophysiology of CLN2 disease and demonstrating reversion by TPP1 gene therapy in hiPSC-derived retinal organoids and retina-on-chip. Cell Rep Med. 2025;0(0). doi:10.1016/j.xcrm.2025.102244
Benedetti MC, D’andrea T, Colantoni A, et al. Cortical neurons obtained from patient-derived iPSCs with GNAO1 p.G203R variant show altered differentiation and functional properties. Heliyon. 2024;10(5). doi:10.1016/j.heliyon.2024.e26656
Fill out the contact form below and a team member will be in touch within one business day.
